POSITIVEID Corp
DelistedCIK 1347022fmd_13K5PCY0TVWZWQR2BC9MGVH25DManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2018, 32 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 1 | 3 | 6 | 5 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 |
| Net interest income | – | – | (0) | (1) | (3) | – | – | – |
| Gross profit | 0 | 0 | 0 | 0 | 1 | 3 | 2 | 2 |
| Research and development | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Selling, general and administrative | 10 | 11 | 7 | 4 | 4 | 6 | 9 | 6 |
| Total operating expenses | 11 | 17 | 8 | 5 | 5 | 7 | 9 | 7 |
| Operating income | (11) | (17) | (8) | (5) | (4) | (4) | (7) | (5) |
| Interest expense | – | – | – | – | 3 | 5 | 8 | 4 |
| Other non-operating income (expense) | 0 | 0 | (0) | 1 | (3) | (7) | (6) | (4) |
| Income before taxes | – | – | (8) | (4) | (7) | (11) | (13) | (9) |
| Income tax expense | – | – | 0 | 0 | 0 | – | – | – |
| Net income from continuing operations | (11) | (16) | (8) | (4) | (7) | – | – | – |
| Net income | (16) | (16) | (8) | (4) | (7) | (11) | (13) | (9) |
| Net income to common shareholders | (16) | (17) | (25) | (13) | (8) | (12) | (13) | (9) |